The US Food and Drug Administration (FDA) has given the go-ahead for an implantable glucose-monitoring device that can remain in the body for up to 90 days. Measurements are sent to the paired app every five minutes. The device, called a glucose monitor, is designed by Medtronic Inc (MDT) and will be available later this year as part of its new Glucose Management System. Comparable external sensors will typically need replacing after just 10 days.
The US Food and Drug Administration (FDA) has given the go-ahead for an implantable glucose-monitoring device that can remain in the body for up to 90 days. The device, called a glucose monitor, is designed by Medtronic Inc (MDT) and will be available later this year as part of its new Glucose Management System. Comparable external sensors will typically need replacing after just 10 days.